Editorial Staff

Public statement on new federal rule eliminating “skimming” of dues from caregivers’ Medicaid payments

/in , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Pioneer Institute applauds a new rule announced by the U.S. Centers for Medicare & Medicaid Services (CMS) that prohibits state governments from automatically deducting union dues from Medicaid payments intended for those caring for loved ones or relatives.

Prior to this action, 13 states (including Massachusetts) classified individuals who take care of relatives and/or loved ones as public employees. A 2014 rule gave unions the ability to collect dues from Medicaid payments made to these caregivers, supposedly to provide benefits including health insurance and skills training.

In an August 2018 comment jointly submitted with other think tanks, Pioneer wrote that allowing diversion of Medicaid funds to third parties, like unions, presents risk of abuse and may result in Medicaid funds being used “for purposes not sanctioned by the Social Security Act.”

Since 2006, collective bargaining agreements in Massachusetts have authorized and subsequently required payment of dues or agency fees for all personal care attendants (PCAs) employed by Medicaid beneficiaries. Eliminating this rule allows individuals to opt into union membership and dues-paying, and disallows automatic deduction of dues on behalf of those caring for relatives or loved ones.

Many organizations involved with this issue, including Pioneer, identified that the 2014 rule allowing “dues skimming” violated the Social Security Act, which says Medicaid payments must be paid directly to caregivers. In addition, given recent U.S. Supreme Court decisions in Harris v. Quinn and Janus v. AFSCME, the 2014 rule creates a First Amendment dilemma, since mandatory payments force people to support political causes favored by unions. Individuals who don’t want to support these causes shouldn’t be forced to join the union, pay dues, or, in this case, have dues “skimmed” from Medicaid payments.

Pioneer believes the new CMS rule is a step toward giving employees the freedom to choose whether to join unions and receive the associated benefits, and ensuring that Medicaid funds of this kind are used to support caregivers and their capacity to aid elderly and disabled members of society.

Get Updates On Our Healthcare Research and Events!

Recent Research:

Study Finds Obstacles to Search for Opioid Substitute

Inflation Reduction Act price controls on the category of…

Transformative Medical Therapy Will Require New Cost-Benefit and Pricing Models

Current regulations increase development and manufacturing costs,…

Genetic Therapy Revolution: Benefits and Barriers for Medicine’s New Horizon

Joe Selvaggi talks with neurobiologist and writer Dr. Anne Sydor about the potential for gene therapy to address deadly and debilitating diseases and how current health care models must adapt to encourage this nascent technology.

Boston Children’s, MGH Among Massachusetts Hospitals with Highest Relative Commercial Prices

Pioneer Institute's new tool, the Massachusetts Hospital Relative Price Tracker, displays relative price and facilitates relative price comparisons among hospitals. The average price among all hospitals will have a relative price of 1.0. A relative price of 1.5 means that a hospital charges 50 percent higher than the average of all Massachusetts hospitals. Similarly, a relative price of 0.84 means that a hospital’s prices are 16 percent below average. Relative price data is collected and reported by the Commonwealth’s Center for Health Information and Analysis (CHIA) and is an aggregate measure used to evaluate price variations among different hospitals. It is recalculated annually based on data collected from commercial payers and includes information on private commercial insurance and commercially managed public insurance products such as Medicare Advantage and Medicaid Managed Organizations/Accountable Care Partnership Plans.

Middlemen Pushing Up Retail Costs of Drugs

The reality is that non-price factors, including several players, are causing net prices to decline and retail prices to increase. Those players include employers, health plans, and pharmacy benefit managers (PBMs), all of whom have continuously circumvented the system through loopholes and complicated systems of reimbursement that tend to hurt patients

Telehealth Progress Slowed in 2023

A new report by Cicero Institute, Pioneer Institute, and Reason Foundation reveals worrying stagnation in state-level telehealth expansion efforts in 2023, with only a few exceptions. Progress made during the pandemic is being lost even as provider shortages worsen, raising concerns about patients’ access to care.

‘High’ U.S. Drug Prices Mask Freeloading by Other Nations

The drug company’s choice is to walk away from millions in revenue from a given country and deny their people a lifesaving drug, or swallow hard and accept an unfair price that is nowhere near the drug’s value. For the sake of shareholders and patients, drug companies typically accept the unfair price and devote the revenue to offsetting their previous investments. In short, other nations are freeloading off of American R&D.

Drug Discount Distortions: How Middlemen Increase Costs and Reduce Access

Joe Selvaggi talks with Drs. Bill Smith and Robert Popovian about how the complex system of rebates from drug companies to insurance firms serve to increase costs and reduce access for patients.

Study: High List Prices and Deep Discounts for Prescription Drugs Hurt Poor and Sick Patients

A new Pioneer Institute study illustrates how the current system of drug pricing and discounts leads to patients with challenging diseases being charged huge out-of-pocket sums to keep other premiums low, effectively imposing financial penalties on the sick to protect the healthy and wealthy.

Out-of-Pocket Pirates: Spotlight on Accumulator & Maximizer Programs

A new white paper, "Out-of-Pocket Pirates: Pharmacy Benefit Managers (PBMs) and the Confiscation of Copayment Assistance Programs," examines how the way these programs are implemented is having negative impacts on patients living with serious diseases.

As COVID-19 Emergencies Ease, Some Progress on Telehealth Rules

A new report from Reason Foundation, Cicero Institute and Pioneer Institute rates every state’s telehealth policy for patient access and ease of providing virtual care. The report highlights telehealth policy best practices for states.

First-of-Its-Kind Interactive Mapping Tool Reveals Extent of For-Profit Entities Benefitting from the 340B Drug Pricing Program

Today, Pioneer Institute released a first-of-its-kind, 50-state mapping tool and database highlighting the troubling way in which hospitals and covered entities leverage unlimited pharmacy contracts under the 340B Drug Pricing Program.

Shopping Hospital Value: Price Transparency Mandate Brings Market Forces to Medicine

Hubwonk host Joe Selvaggi talks with Pioneer Institute's senior healthcare fellow Barbara Anthony about her recently released paper, Massachusetts Hospitals: Uneven Compliance with New Federal Price Transparency Law, and how price transparency can empower consumers to shop for better value and encourage hospitals to offer more competitive costs.

Survey Finds Spotty Compliance Among Hospitals with Federal Price Transparency Law

A 2019 federal law requires hospitals to make prices for 300 shoppable services available online in a “consumer-friendly format,” but a Pioneer Institute survey of 19 hospitals finds that information on discounted cash prices—the price most likely to be charged to consumers paying out of pocket—was unavailable at seven of those hospitals.

Right To Save: Paying Healthcare Consumers To Shop For Value

This week on Hubwonk, host Joe Selvaggi talks with healthcare policy expert Josh Archambault about the findings from his Cicero Institute report, The Right to Save: The Next Generation of Price Transparency. He outlines how to incentivize healthcare consumers to utilize price information to reduce out-of-pocket costs, and lower healthcare costs for everyone.